BiomX (PHGE) Non Operating Income (2023 - 2025)
BiomX (PHGE) posted Non Operating Income of $22000.0 for Q4 2025, down 73.81% sequentially from $84000.0 in Q3 2025, and down 88.11% YoY from $185000.0 in Q4 2024.
BiomX (PHGE) Non Operating Income (2023 - 2025) Analysis & Trends
BiomX has reported Non Operating Income for 3 years, with the latest figure at $22000.0 in Q4 2025.
- Quarterly Non Operating Income fell 88.11% year-over-year to $22000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $266000.0 (up 120.31% YoY) and the FY2025 annual result came in at -$724000.0, up 21.22% from the prior year.
- Non Operating Income declined to $22000.0 in Q4 2025 per PHGE's latest filing, from $84000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $382000.0 in Q3 2023 and troughed at -$2.2 million in Q4 2023.
- A 3-year average of -$58000.0 and a median of $185000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 108.58% in 2024, then plunged 107.6% in 2025.
- Over 3 years, Non Operating Income stood at -$2.2 million in 2023, then jumped by 108.58% to $185000.0 in 2024, then sank by 88.11% to $22000.0 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered $22000.0, $84000.0, and -$25000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 332,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Dec 31, 2023 | -2.16 Mn |
| Sep 30, 2023 | 382,000.00 |
| Jun 30, 2023 | 325,000.00 |